Is the Pfizer/BioNTech vaccine effective against COVID-19 mutations? Scientists have the answer
A team of scientists from Pfizer and Texas University have found that the Pfizer/BioNTech vaccine appears to be effective against a key mutation.
A team of scientists from Pfizer and Texas University have found that the Pfizer/BioNTech vaccine appears to be effective against a key mutation.
Pfizer said its two-dose vaccine, BNT162b2, was consistently effective across different ages and ethnic groups, well-tolerated and that side effects were mostly mild to moderate.
Pfizer and German partner BioNTech SE have announced preliminary results of the large-scale clinical trial of their COVID-19 vaccine candidate.